3 May 2023 - Quviviq is indicated for the management of adult patients with insomnia, characterized by difficulties with sleep onset ...
1 May 2023 - Approval marks second first-line indication in NSCLC and fifth indication for Libtayo in Canada. ...
28 April 2023 - First Zoryve approval outside of the US marks key milestone for Arcutis. ...
22 April 2023 - Health Canada has approved a new antibody drug to help protect babies from serious illness caused ...
17 April 2023 - AbbVie today announced that Vraylat is now listed as an exception medication status on the list of ...
17 April 2023 - New treatment option for Canadians living with rare and serious X-chromosome linked congenital bleeding disorder ...
14 April 2023 - Indications under review include prevention of respiratory syncytial virus in infants from birth through 6 months ...
10 April 2023 - With this approval, approximately 30 children with two copies of the F508del mutation are eligible for ...
3 April 2023 - First and only therapy approved to treat this rare and debilitating genetic condition. ...
31 March 2023 - New formulation allows twice-daily dosing in patients with transfusional iron overload due to thalassaemia syndromes when ...
23 March 2023 - Landmark ZUMA-7 study demonstrated patients on Yescarta were 2.5 times more likely to be alive at ...
23 March 2023 - All oral, once daily, fixed duration combination regimen authorised for first-line treatment of CLL. ...
25 March 2023 - Authorization is based on results from the Phase 1/2 NP30179 study, which demonstrated Columvi induced durable response ...
24 March 2023 - In the EFFISAYIL-1 trial, over half of the Spevigo (spesolimab) treated patients were free of pustules, ...
5 March 2023 - According to industry sources on Sunday, SB11 was introduced to the Canadian market last Wednesday through its ...